Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Controlled Trial to Evaluate the Efficacy of Cognitive Remediation Within a Secure Forensic Setting for Schizophrenia Spectrum Patients

NCT02360813 is registered in ClinicalTrials.gov with Central Mental Hospital as lead sponsor.

NCT NCT02360813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02360813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Controlled Trial to Evaluate the Efficacy of Cognitive Remediation Within a Secure Forensic Setting for Schizophrenia Spectrum Patients
Lead sponsor
Central Mental Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2014
Completion date
January 31, 2017
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive deficits, schizoaffective disorder, schizophrenia